Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial (Lancet, 2022)

(untitled) - Thriemer, K; Degaga, TS; Christian, M; Alam, MS; Rajasekhar, M; Ley, B; Hossain, MS; Kibria, MG; Tego, TT; Abate, DT; Weston, S; Mnjala, H; et al.